Sign in

CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475617627
Phone
(617) 231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
  1. 4 Other acquisition Director acquired 115,415 shares (other)
  2. 4 Other acquisition Director acquired 84,475 shares (other)
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. 8-K Event Other events
  6. S-1 Offering Registration Statement
  7. 8-K Event Other events
  8. 8-K Event Regulation FD disclosure
  9. 4 Open-market sale Director sold 755 shares at $37.12 ($28,026)
  10. UPLOAD Other SEC-generated Letter
  11. 8-K Event Executive or director change
  12. DRS Other Draft Registration Statement
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. 8-K Event Executive or director change
  16. DEFA14A Proxy Proxy Materials
  17. DEF 14A Proxy Proxy Statement
  18. 4 Option exercise Director acquired 711 shares (option exercise)
  19. 4 Grant or award Director acquired 233 shares (grant or award)
  20. 4 Open-market sale Chief Medical Officer sold 15,000 shares at an average $37.77 ($566,536)

Page 24 of 28 · 548 filings